Socioeconomic factors increase risk for age-related macular degeneration
By
HealthDay News
Sep 25, 2024
A healthy lifestyle, however, can mitigate some of the risks associated with low socioeconomic status.
Vision loss: Signs, symptoms and technology that can help
By
Roland Mattern
Katelyn Jordan, OD, FAAO
Sep 26, 2024
Vision loss can greatly affect your residents’ or employees’ quality of life and ability to perform normal activities such as reading, connecting with loved ones, or driving. Fortunately, rapid advances...
Portable, low-cost eye scanner $20 million closer to coming to you
By
Aaron Dorman
Mar 22, 2024
Eye scanner developers recently received $20 million to produce a low-cost, easy-to-use method to detect and preempt vision loss.
Living with low vision: AMD
By
Aaron Tutwiler
Sep 28, 2023
seniors living with AMD and other vision issues have a plethora of options available, from injectable treatments to assistive technologies and other developing medications.
Eye ointments sold at Walmart, CVS recalled due to infection risk
Feb 27, 2024
Eye ointment products made in India and sold in the United States at Walmart, CVS and other retailers are being recalled due to a danger of infection.
‘Smart’ glasses, mobility tools part of dynamic slate of senior tech getting seed funding
By
Aaron Dorman
Feb 21, 2024
Eleven senior tech projects will receive funding and support from the Design Age Institute in London, from apps to mobility solutions.
Big city (blue) lights: Urban light pollution could be speeding up age-related macular degeneration in...
By
Aaron Dorman
Jan 23, 2024
Light pollution from urban areas can have a negative effect on eyesight by increasing risk of age-related macular degeneration, a study shows.
Old devices are new again thanks to AI, aging expert says
By
Aaron Dorman
Jan 22, 2024
The major trend at CES 2024 was that a lot of tech is being rebooted with artificial intelligence capabilities, one expert observed.
AI model can respond appropriately to ophthalmology questions
Aug 25, 2023
The likelihood of chatbot answers containing incorrect or inappropriate material was comparable with human answers.
FDA approves Izervay for geographic atrophy tied to age-related macular degeneration
Aug 09, 2023
Two trials show significant slowing of geographic atrophy progression at the 12-month primary end point.